Jubilant Pharmova Ltd
Fortune 500 2025
+ 15 More
+ 15 More
Share
Share
OVERVIEW
FINANCIALS
Featured In Fortune India Ranking
Fortune 500 India
#334(2025)
#331(2024)
#332(2023)
#273(2022)
#217(2021)
#152(2020)
#169(2019)
#188(2018)
#212(2017)
#216(2016)
#203(2015)
#196(2014)
#207(2013)
#215(2012)
#232(2011)
#181(2010)
#334(2025)#331(2024)#332(2023)#273(2022)#217(2021)#152(2020)#169(2019)#188(2018)#212(2017)#216(2016)#203(2015)#196(2014)#207(2013)#215(2012)#232(2011)#181(2010)
Financial Data 2024
Revenue
6,718
(INR Cr)
Net Operating Income
6,703
(INR Cr)
Assets
9,748
(INR Cr)
Profit
77
(INR Cr)
Net Worth
5,434
(INR Cr)
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 6718 5.4% | 6373 2.7% | 6204 -2.6% | 6370 0.0% | 6371 -30.4% | 9148 20.2% | 7610 26.8% | 6002 3.4% | 5803 0.0% | 5803 -2.2% | 5936 13.2% | 5243 15.9% | 4523 29.2% | 3501 -8.9% | 3844 4.0% | 3698 - |
| Net Operating Income (INR Cr) | 6703 6.71% | 6282 2.47% | 6130 0.52% | 6099 2.05% | 5976 -34.41% | 9111 21.19% | 7518 28.26% | 5861 1.95% | 5749 -1.32% | 5826 0.39% | 5803 12.34% | 5166 20.05% | 4303 24.89% | 3446 -9.13% | 3792 7.79% | 3518 41.38% |
| Profit (INR Cr) | 77 - | -61 - | 414 -50.5% | 836 -6.9% | 898 56.4% | 574 -10.6% | 643 11.7% | 576 46.9% | 392 - | -58 - | 109 -28.6% | 153 949.0% | 15 -93.7% | 230 -45.5% | 421 48.8% | 283 - |
| Assets (INR Cr) | 9748 3.4% | 9431 9.5% | 8612 12.0% | 7692 -27.2% | 10572 8.2% | 9774 24.2% | 7871 2.1% | 7710 0.9% | 7641 3.9% | 7353 -0.8% | 7411 4.7% | 7077 12.1% | 6314 2.2% | 6180 14.2% | 5412 -1.9% | 5516 - |
| Net Worth (INR Cr) | 5434 0.6% | 5399 1.5% | 5319 12.2% | 4741 -15.4% | 5604 16.5% | 4809 17.7% | 4087 18.9% | 3436 15.8% | 2966 20.9% | 2454 -6.6% | 2627 6.1% | 2476 9.7% | 2257 3.9% | 2172 -1.3% | 2201 42.7% | 1543 22.8% |
| Employee Cost (INR Cr) | 2216 2.3% | 2166 6.0% | 2043 6.3% | 1923 4.3% | 1843 -4.3% | 1926 23.8% | 1556 26.4% | 1231 9.4% | 1125 3.2% | 1090 -1.4% | 1105 14.8% | 963 15.1% | 836 16.4% | 719 -3.6% | 745 11.7% | 667 - |
| Interest Cost (INR Cr) | 272 | 188 | 145 | 184 | 200 | 220 | 284 | 341 | 371 | 368 | 337 | 311 | 238 | 120 | 69 | 326 |
| Cash & Bank Balance (INR Cr) | 957 | 1014 | 984 | 671 | 1400 | 1370 | 249 | 460 | 345 | 394 | 480 | 356 | 267 | 1045 | 504 | 382 |
| Total Debt (INR Cr) | 3664 | 3677 | 3192 | 2830 | 4808 | 4840 | 3469 | 4045 | 4493 | 4793 | 4395 | 4245 | 3818 | 3926 | 3173 | 3942 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 1.2% | - | 6.7% | 13.1% | 14.1% | 6.3% | 8.5% | 9.6% | 6.8% | - | 1.8% | 2.9% | 0.3% | 6.6% | 11.0% | 7.7% |
| Profit As % Of Assets | 0.8% | - | 4.8% | 10.9% | 8.5% | 5.9% | 8.2% | 7.5% | 5.1% | - | 1.5% | 2.2% | 0.2% | 3.7% | 7.8% | 5.1% |
| Profit As % Of Networth | 1.4% | - | 7.8% | 17.6% | 16.0% | 12.0% | 15.7% | 16.8% | 13.2% | - | 4.2% | 6.2% | 0.7% | 10.6% | 19.2% | 18.4% |
| Interest Cost to EBITDA % | 37.2% | 26.2% | 12.7% | 13.4% | 13.2% | 15.1% | 18.7% | 25.4% | 29.8% | 62.6% | 42.6% | 35.5% | 44.0% | 22.9% | 10.2% | 47.6% |
| Debt to Equity Ratio | 0.67 | 0.68 | 0.60 | 0.60 | 0.86 | 1.01 | 0.85 | 1.18 | 1.51 | 1.95 | 1.67 | 1.71 | 1.69 | 1.81 | 1.44 | 2.56 |
| RONW | 0.8% | - | 8.2% | 16.6% | 17.3% | 16.7% | 16.9% | 18.0% | 14.3% | - | 8.8% | 10.4% | 14.2% | 11.4% | 22.1% | 18.9% |
| ROCE | 6.4% | 3.1% | 9.5% | 11.9% | 14.1% | 15.9% | 14.6% | 14.0% | 12.2% | 5.9% | 10.5% | 11.6% | 11.2% | 6.9% | 10.7% | 14.0% |